NCT07001618 2026-04-03IMMUNOLIFE2Gustave Roussy, Cancer Campus, Grand ParisPhase 2 Recruiting162 enrolled
NCT02486718 2026-02-05Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]Hoffmann-La RochePhase 3 Active not recruiting1,280 enrolled 24 charts 2 FDA
NCT03456076 2026-01-30A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung CancerHoffmann-La RochePhase 3 Active not recruiting257 enrolled 14 charts 2 FDA